GSK Pharma's Q3 Profit Jumps 35% on Strong Demand for Augmentin, Respiratory Drugs Farhat Nasim16 Feb 2025 11:45 AM ISTBengaluru: India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its...
GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files lawsuit MD Bureau16 Oct 2024 3:51 PM ISTLondon: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating...
Alembic Pharma secures USFDA nod for Seizure treatment drug Lamotrigine ER Ruchika Sharma3 Oct 2024 1:33 PM ISTVadodara: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
CDSCO Panel grants GSK's Protocol Amendment Proposal To Study Belantamab mafodotin Dr. Divya Colin1 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Submit details of adverse events reported: CDSCO Panel Tells GSK on Mepolizumab Powder for Solution for Injection Dr. Divya Colin24 Aug 2024 6:00 PM ISTNew Delhi: In line with the Phase IV clinical trial report of the monoclonal antibody Mepolizumab (Brand Name: Nucala 100 mg) presented by the drug...
Modify CT Protocol: CDSCO Panel Tells GSK on Respiratory Syncytial Virus(RSV) Vaccine Dr. Divya Colin24 March 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial protocol presented by the drug major GSK for the Respiratory Syncytial Virus (RSV) vaccine...
CDSCO Panel grants GSK's Updated Prescribing Information for Antibiotic FDC of Amoxicillin, Clavulanic acid Dr. Divya Colin21 March 2024 5:45 PM ISTNew Delhi: The drug major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
GSK gets CDSCO Panel Nod To study Anti-cancer Drug Belantamab mafodotin Dr. Divya Colin25 Feb 2024 6:00 PM ISTNew Delhi: The drug major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Submit Separate Toxicity Data on Indian Subject: CDSCO Panel Tells GSK on BelantamabMafodotin study Dr. Divya Colin4 Jan 2024 6:00 PM ISTNew Delhi: Considering the serious adverse events in the study data (phase-I & II) of Belantamab Mafodotin (GSK2857916) for Injection 100mg...
GSK Gets CDSCO Panel Nod to study safety of anti-cancer drug Dostarlimab Dr. Divya Colin23 Dec 2023 6:00 PM ISTNew Delhi: Citing that the total number of evaluable patients in the study should be a minimum of 30, the Subject Expert Committee (SEC) functional...
Turkey launches investigation into 19 pharma cos Ruchika Sharma1 Dec 2023 12:49 PM ISTAnkara: Turkey's competition authority said on Thursday it had launched an investigation into 19 pharmaceutical companies to determine whether they...
US Supreme Court rejects Teva challenge to USD 235 million GSK award in patent dispute Ruchika Sharma16 May 2023 2:44 PM ISTGSK responded in a court brief that the case "presents no threat to generic companies who operate properly under the law."
